Found: 5
Select item for more details and to access through your institution.
Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice.
- Published in:
- Endocrinology & Metabolism, 2017, v. 32, n. 1, p. 115, doi. 10.3803/EnM.2017.32.1.115
- By:
- Publication type:
- Article
Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
- Published in:
- Diabetes & Metabolism Journal, 2019, v. 43, n. 6, p. 830, doi. 10.4093/dmj.2018.0181
- By:
- Publication type:
- Article
Low-Normal Free Thyroxine Levels in Euthyroid Male Are Associated with Prediabetes.
- Published in:
- Diabetes & Metabolism Journal, 2019, v. 43, n. 5, p. 718, doi. 10.4093/dmj.2018.0222
- By:
- Publication type:
- Article
Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome.
- Published in:
- Diabetes & Metabolism Journal, 2018, v. 42, n. 3, p. 207, doi. 10.4093/dmj.2017.0081
- By:
- Publication type:
- Article
508-P: Gemigliptin Ameliorates Renal Fibrosis by Attenuating NLRP3-Mediated Inflammation in a Murine Model.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-508-P
- By:
- Publication type:
- Article